Keywords: مهار کننده ترانس کپیک معکوس غیر نوکلئوزیدی; AIDS; acquired immunodeficiency syndrome; AUC; area under the plasma concentration versus time curve of NVP in absence of NT; AUCI; area under the plasma concentration versus time curve of NVP in presence of NT; AUCratio; ratio between AUCI and AUC (AUCI/
مقالات ISI مهار کننده ترانس کپیک معکوس غیر نوکلئوزیدی (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: مهار کننده ترانس کپیک معکوس غیر نوکلئوزیدی; HIV; human immunodeficiency virus; RT; reverse transcriptase; NNRTI; non-nucleoside reverse transcriptase inhibitor; NRTI; nucleoside reverse transcriptase inhibitor; WT; wild-type; K101P; Lysine101Proline; IC50; inhibition concentration at 50%; EC50; eff
Keywords: مهار کننده ترانس کپیک معکوس غیر نوکلئوزیدی; Transmission; Pharmacogenomics; Incipient tuberculosis; HIV; Diabetes; Biomarkers; DAIDS; Division of AIDS; NIAID; National Institute of Allergy and Infectious Diseases; NIH; National Institutes of Health; TB; tuberculosis; RePORT; Regional Prospective Ob
Keywords: مهار کننده ترانس کپیک معکوس غیر نوکلئوزیدی; ARV; antiretroviral; ART; antiretroviral treatment; EID; Early Infant Diagnosis of HIV; HIV; Human Immunodeficiency Virus type-1; HIVDR; HIV drug resistance; NA; not applicable; NNRTI; non-nucleoside reverse transcriptase inhibitor; NRTI; nucleoside rever
Keywords: مهار کننده ترانس کپیک معکوس غیر نوکلئوزیدی; X-ray crystallography; Fragment screening; HIV; Influenza; BpGCDH; B. pseudomallei glutaryl-CoA dehydrogenase; DHNA; 7,8-dihydroneopterin aldolase; DMSO; dimethylsulfoxide; FBDD; fragment-based drug discovery; HCV; hepatitis C virus; HIV; human immunodef
Time spent with residual viraemia after virological suppression below 50 HIV-RNA copies/mL according to type of first-line antiretroviral regimen
Keywords: مهار کننده ترانس کپیک معکوس غیر نوکلئوزیدی; Residual viraemia; Elvitegravir/cobicistat; Dolutegravir; Non-nucleoside reverse transcriptase inhibitor; Integrase inhibitor; Protease inhibitor;
HIV-1 integrase inhibitor resistance among treatment naïve patients in the West of Scotland
Keywords: مهار کننده ترانس کپیک معکوس غیر نوکلئوزیدی; PI; protease inhibitor; NRTI; nucleoside reverse transcriptase inhibitor; NNRTI; non-nucleoside reverse transcriptase inhibitor; HAART; highly active anti-retroviral therapy; TDR; transmitted drug resistance; IDU; injecting drug user; MSM; men who have se
Efavirenz dissolution enhancement III: Colloid milling, pharmacokinetics and electronic tongue evaluation
Keywords: مهار کننده ترانس کپیک معکوس غیر نوکلئوزیدی; EFV; efavirenz; NNRTI; non-nucleoside reverse transcriptase inhibitor; HIV-1/AIDS; human immunodeficiency virus type 1 infection; SLS; sodium lauryl sulfate; HPC; hydroxypropylcellulose; HPMC; hydroxypropylmetilcellulose; NRTIs; nucleoside reverse transcr
Predicting CD4 count changes among patients on antiretroviral treatment: Application of data mining techniques
Keywords: مهار کننده ترانس کپیک معکوس غیر نوکلئوزیدی; CD4 count change; Antiretroviral treatment; Computational methods; Random Forest; Neural Network; J48, Decision tree; ABC; Abacavir; ddI; Didanosine; d4T; Stavudin; EFV; Efavirenz; FTC; Emotricitabine; LPV/r; Lopinavir/ritonavir; NFV; Nelfinavir; NNRTI; N
A qualitative PCR minipool strategy to screen for virologic failure and antiretroviral drug resistance in South African patients on first-line antiretroviral therapy
Keywords: مهار کننده ترانس کپیک معکوس غیر نوکلئوزیدی; ART; antiretroviral therapy; WHO; World Health Organisation; PI; protease inhibitor; DBS; dried blood spot; ADR; antiretroviral drug resistance; NHLS; National Health Laboratory Service; RT; Reverse Transcriptase Coding Region of Pol Gene; NNRTI; non-nucl
The phenolic metabolites of the anti-HIV drug efavirenz: Evidence for distinct reactivities upon oxidation with Frémy's salt
Keywords: مهار کننده ترانس کپیک معکوس غیر نوکلئوزیدی; Efavirenz; Phenolic metabolites; Oxidation; Quinone-imine; Quinoline; Anti-HIV drug; CYP; cytochrome P450; EFV; efavirenz; ESI; electrospray ionization; HIV; human immunodeficiency virus type 1; HPLC-DAD; high performance liquid chromatography with diod
Complete and repeatable inactivation of HIV-1 viral particles in suspension using a photo-labeled non-nucleoside reverse transcriptase inhibitor
Keywords: مهار کننده ترانس کپیک معکوس غیر نوکلئوزیدی; HIV-1 photo-inactivation; Non-nucleoside reverse transcriptase inhibitor;
Evaluation of the automatic editing tool RECall for HIV-1 pol and V3 loop sequences
Keywords: مهار کننده ترانس کپیک معکوس غیر نوکلئوزیدی; AA; amino acid; ART; antiretroviral therapy; env; envelope gene; EQA; external quality assessment; FPR; false positive rate; HIV-1; human immunodeficiency virus type 1; NNRTI; non-nucleoside reverse transcriptase inhibitor; NRTI; nucleoside reverse transc
Analysis of primary resistance mutations to HIV-1 entry inhibitors in therapy naive subtype C HIV-1 infected mother-infant pairs from Zambia
Keywords: مهار کننده ترانس کپیک معکوس غیر نوکلئوزیدی; HIV-1; human immunodeficiency virus type 1; MTCT; mother-to-child transmission; MIP; mother-infant pair; NNRTI; non-nucleoside reverse transcriptase inhibitor; DRAM; drug resistance-associated mutation; IFA; immunofluorescence assay; PBMC; peripheral bl
Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation
Keywords: مهار کننده ترانس کپیک معکوس غیر نوکلئوزیدی; Biotransformation; Cytochrome P450 monooxygenase; NADPH:cytochrome P450 reductase; Pharmacogenetics; Polymorphism; Xenobiotic; ADME; absorption, distribution, metabolism, excretion; ADR; adverse drug reaction; AhR; aromatic hydrocarbon receptor; CNV; copy
Development and evaluation of an assay for HIV-1 protease and reverse transcriptase drug resistance genotyping of all major group-M subtypes
Keywords: مهار کننده ترانس کپیک معکوس غیر نوکلئوزیدی; ART; antiretroviral therapy; DBS; dried blood spot; LOD; limit of detection; NNRTI; non-nucleoside reverse transcriptase inhibitor; NRTI; nucleoside reverse transcriptase inhibitor; Nt; nucleotide; PI; protease inhibitor; PMTCT; prevention-of-mother-to-ch
Profile of stress and toxicity gene expression in human hepatic cells treated with Efavirenz
Keywords: مهار کننده ترانس کپیک معکوس غیر نوکلئوزیدی; EFV; Efavirenz; HAART; highly active antiretroviral therapy; NRTI; nucleoside reverse transcriptase inhibitor; NNRTI; non-nucleoside reverse transcriptase inhibitor; ROS; reactive oxygen species; ÎΨm; mitochondrial transmembrane potential; DNA; polymera
Development and validation of LC-ESI-MS method for sensitive, accurate and rapid determination of UC-781 in New Zealand white rabbit plasma
Keywords: مهار کننده ترانس کپیک معکوس غیر نوکلئوزیدی; UC-781; HIV; Extraction; Antiretroviral; Non-nucleoside reverse transcriptase inhibitor; LC-MS; Chromatography;
Design and synthesis of pyridone inhibitors of non-nucleoside reverse transcriptase
Keywords: مهار کننده ترانس کپیک معکوس غیر نوکلئوزیدی; Non-nucleoside reverse transcriptase inhibitor; Pyridone; Pyridinone; HIV
Vitamin D Supplementation and CD4 Count in Children Infected with Human Immunodeficiency Virus
Keywords: مهار کننده ترانس کپیک معکوس غیر نوکلئوزیدی; 25(OH)D; 25-hydroxyvitamin D; 1,25(OH)2D; 1,25-dihydroxyvitamin D; cART; Combination antiretroviral therapy; CDC; Centers for Disease Control and Prevention; HIV; Human immunodeficiency virus; NNRTI; Non-nucleoside reverse transcriptase inhibitor; NRTI; N
Synthesis and anti-HIV activity of 2â²-deoxy-2â²-fluoro-4â²-C-ethynyl nucleoside analogs
Keywords: مهار کننده ترانس کپیک معکوس غیر نوکلئوزیدی; HIV-1; human immunodeficiency virus type-1; RT; reverse transcriptase; NRTI; nucleoside reverse transcriptase inhibitor; NNRTI; non-nucleoside reverse transcriptase inhibitor; dN; 2â²-deoxynucleoside; ddN; 2â²,3â²-dideoxynucleoside; AZT; zidovudine; SA
Similar Progression of Fibrosis Between HIV/HCV-Infected and HCV-Infected Patients: Analysis of Paired Liver Biopsy Samples
Keywords: مهار کننده ترانس کپیک معکوس غیر نوکلئوزیدی; Hepatitis C Disease Progression; Coinfection; Human Immunodeficiency Virus; ALP; alkaline phosphatase; APRI; AST to platelet ratio; AUC; area under the curve; HAART; highly active antiretroviral therapy; HAI; histologic activity index; HIV; human immunode
Effect of steady-state etravirine on the pharmacokinetics and pharmacodynamics of ethinylestradiol and norethindrone ★
Keywords: مهار کننده ترانس کپیک معکوس غیر نوکلئوزیدی; Oral contraceptives; Ethinylestradiol; Norethindrone; TMC125; Etravirine; Non-nucleoside reverse transcriptase inhibitor; Drug–drug interaction; Pharmacokinetics
Investigation of the alkenyldiarylmethane non-nucleoside reverse transcriptase inhibitors as potential cAMP phosphodiesterase-4B2 inhibitors
Keywords: مهار کننده ترانس کپیک معکوس غیر نوکلئوزیدی; PDE4B2; Phosphodiesterase; HIV-1; Non-nucleoside reverse transcriptase inhibitor; NNRTI; Alkenyldiarylmethane; ADAM;
Mutations other than 103N in human immunodeficiency virus type 1 reverse transcriptase (RT) emerge from K103R polymorphism under non-nucleoside RT inhibitor pressure
Keywords: مهار کننده ترانس کپیک معکوس غیر نوکلئوزیدی; K103R; Polymorphic; Mutation; Non-nucleoside reverse transcriptase inhibitor; Resistance; HIV-1
Polyunsaturated fatty acids inhibit telomerase activity in DLD-1 human colorectal adenocarcinoma cells: A dual mechanism approach
Keywords: مهار کننده ترانس کپیک معکوس غیر نوکلئوزیدی; hTR; human telomerase RNA component; TP1; telomerase-associated protein 1; hTERT; human telomerase reverse transcriptase; PUFAs; polyunsaturated fatty acids; EPA; eicosapentaenoic acid; DHA; docosahexaenoic acid; LDH; lactate dehydrogenase; PBS; phosphate
Crystallography and the design of anti-AIDS drugs: conformational flexibility and positional adaptability are important in the design of non-nucleoside HIV-1 reverse transcriptase inhibitors
Keywords: مهار کننده ترانس کپیک معکوس غیر نوکلئوزیدی; Dapivirine; TMC120-R147681; Drug design; Drug resistance; Etravirine; TMC125-R165335; 3DSAR; Three-dimensional structure-activity relationships; DAPY; Diarylpyrimidine; DATA; Diaryltriazine; dsDNA; Double-stranded DNA; HAART; Highly active antiretroviral